Two-Center, Randomized, Placebo and Active Comparator Evaluation of the Pharmacokinetics (PK) and Safety, Along with Initial Pharmacodynamic (PD) Efficacy of Three Dose Levels of TBS-2 Intranasal Gel Applied Twice-Daily (BID) for up to Three Days in Female Subjects with Hypoactive Sexual Desire Disorder (HSDD) or Anorgasmia (ANOR).
Phase of Trial: Phase I/II
Latest Information Update: 03 Aug 2011
At a glance
- Drugs Testosterone (Primary)
- Indications Anorgasmia; Decreased libido
- Focus Pharmacokinetics
- 02 Jun 2011 New trial record